SCHOTT Pharma AG & Co. KGaA is a leading global provider of pharmaceutical packaging solutions, specializing in primary drug containment and delivery systems for injectable medications. Headquartered ... SCHOTT Pharma AG & Co. KGaA is a leading global provider of pharmaceutical packaging solutions, specializing in primary drug containment and delivery systems for injectable medications. Headquartered in Mainz, Germany, the company draws on over 130 years of expertise in glass science as part of the SCHOTT AG group, employing around 4,700 people across 16 GMP-compliant manufacturing sites in Europe, North America, South America, and Asia. Its core portfolio includes high-quality vials, syringes, cartridges, and ampoules made from Type I borosilicate glass or medical-grade cyclic olefin copolymer (COC) polymer, such as the syriQ® glass syringes, TOPPAC® polymer syringes, cartriQ® cartridges, and innovative EVERIC® vials. These products ensure drug stability for biologics, vaccines, and mRNA therapies, even under ultra-cold storage, while minimizing interactions and supporting efficient fill-finish processes. SCHOTT Pharma also offers value-added services like packaging design, regulatory support, and sustainability initiatives. In the financial markets, it plays a vital role supplying pharmaceutical and biotechnology firms, enabling safe, reliable drug delivery amid rising demand for advanced injectables.
No Climate Targets data disclosed by SCHOTT Pharma AG & Co
We reviewed SCHOTT Pharma AG & Co's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.
If you would like us to review newly published materials or reassess the most recent
disclosures, you can submit a data update request.